Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Induction of local lesion cell death is a process by which cells at a localized site undergo programmed cell death, often as a defense mechanism, in response to stress, damage, or infection. It involves regulated pathways such as apoptosis, necroptosis, or parthanatos, triggered by various stimuli including pathogen recognition, DNA damage, and high extracellular ATP. This process serves critical functions like pathogen containment, removal of damaged cells, and as a target for cancer therapy. Key molecules involved include caspases, death receptors, mitochondrial proteins, and adaptor proteins.
Various, depending on the inducer and pathway involved. Includes caspase activation, mitochondrial outer membrane permeabilization, PARP activation, and death receptor signaling.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Induction of Local Lesion Cell Death (LLCD).